Valneva

Valneva Enterprise Value

The Enterprise Value (EV) of Valneva (VLA.PA) as of Oct 13, 2026 is 861.24 M EUR. In the previous year, Enterprise Value (EV) was 837.02 M EUR — a change of 2.89% (higher).

Enterprise Value

861.24 MEUR

YoY

2.89%

Last updated:

Enterprise Value (EV) of Valneva is 2025 861.24 M EUR. Enterprise Value (EV) of Valneva was 2024 837.02 M EUR. It decreases by 2.89% higher compared to the previous year.

The Valneva Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
769.49 M EUR
Jan 1, 2019
809.76 M EUR
Jan 1, 2020
690.04 M EUR
Jan 1, 2021
556.99 M EUR
Jan 1, 2022
651.93 M EUR
Jan 1, 2023
871.72 M EUR
Jan 1, 2024
837.02 M EUR
Jan 1, 2025
861.24 M EUR
The Valneva Enterprise Value history
YEAREnterprise ValueYoY
861.24 MEUR+2.89%
837.02 MEUR-3.98%
871.72 MEUR+33.71%
651.93 MEUR+17.04%
556.99 MEUR-19.28%
690.04 MEUR-14.78%
809.76 MEUR+5.23%
769.49 MEUR-6.95%
826.93 MEUR-1.11%
836.22 MEUR-1.54%
849.33 MEUR+1.93%
833.26 MEUR—
Access this data via the Eulerpool API

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Enterprise Value (EV) of Valneva is 861.24 M EUR in 2025.

Enterprise Value (EV) of Valneva changed from 837.02 M EUR to 861.24 M EUR, representing a 2.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Valneva since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s EUR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' EUR varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Valneva with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Valneva

All Key Metrics — Valneva